Nanomedicine News

RSS

New Data Highlighting Key Milestones in Development of Novel Non-Inflammatory Nanoemulsion Technology

NanoBio Corp. announced today that it will present compelling new data highlighting key milestones in the development of its novel non-inflammatory nanoemulsion adjuvant platform technology at the National Foundation for Infectious Diseases (NFID) conference, April 27-29.

23 Apr 2009

First Major Study of Media Coverage, Policy Debates and Public Perceptions about Nanotechnology

The first major study of media coverage, policy debates and public perceptions about nanotechnology is the focus of a new book co-authored by Professor Stuart Allan of Bournemouth University.

23 Apr 2009

Researchers Using Nanotechnology to Develop Low-Cost Disposable Blood-Testing Kits

Professor Peter Ashburn is leading a team of University researchers who are developing low-cost, disposable blood-testing kits that can be made available in GPs' surgeries.

23 Apr 2009

Nanoparticle that Transports Antitumor Genes Selectively to Cancer Cells

Cancer researchers have been exploring gene therapy as an experimental treatment to fight the deadly disease despite the obstacles that have surfaced along the way. A cross-European research team has now gained a foothold in this area by developing a nanoparticle that transports antitumor genes selectively to cancer cells.

23 Apr 2009

Report Examines the Biomedical Applications of Electroactive Polymer Actuators

Research and Markets has announced the addition of John Wiley and Sons Ltd's new report "Biomedical Applications of Electroactive Polymer Actuators" to their offering.

From Research and Markets 23 Apr 2009

Roche NimbleGen and Sigma-Aldrich Started Collaboration to Further ChIP-chip Research

Roche NimbleGen and Sigma-Aldrich (Nasdaq:SIAL) have started a collaboration to further chromatin immunoprecipitation-on-microarray (ChIP-chip) research by aligning their two complementary technologies, Roche NimbleGen's ChIP-chip high-density microarrays and GenomePlex by Sigma-Aldrich.

From Sigma Aldrich 23 Apr 2009

BioAlliance Pharma Presents Results on New Biotherapy at AACR Annual Meeting

BioAlliance Pharma SA (Paris:BIO), a specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, has presented results on its new biotherapy, plasmid AMEP™, for metastatic melanoma treatment at the at the American Association for Cancer Research (AACR) 100th Annual Meeting, in Denver, April 18 to 22, 2009.

22 Apr 2009

Nanomedicine News

New Data Highlighting Key Milestones in Development of Novel Non-Inflammatory Nanoemulsion Technology

First Major Study of Media Coverage, Policy Debates and Public Perceptions about Nanotechnology

Researchers Using Nanotechnology to Develop Low-Cost Disposable Blood-Testing Kits

Nanoparticle that Transports Antitumor Genes Selectively to Cancer Cells

Report Examines the Biomedical Applications of Electroactive Polymer Actuators

Roche NimbleGen and Sigma-Aldrich Started Collaboration to Further ChIP-chip Research

BioAlliance Pharma Presents Results on New Biotherapy at AACR Annual Meeting

CRi Introduces Vectra Intelligent Slide Analysis System

Fast Color-Changing Material Leads to More Powerful Computers

Enable IPC Accepts Invitation to Join the Advanced Materials Industrial Consortium at University of Wisconsin

Combining Nanofluids and Turbulators for Sustainable Energy

Enhancing Material Properties through Nanotube Encapsulation

Brain-Inspired Nano-Tech Promises New Era for Electronics

Breakthrough in 2D Material Growth Opens Doors to Cleaner Energy and Next-Generation Technology

Sustainable ZnO Nanoparticles for Methylene Blue Cleanup

Electrospinning and the Future of Nanotechnology

How Electrospinning is Shaping the Future of Nanotechnology

Conversations on AFM: Applications of BioAFM in Life Science

Sponsored Content

Characterization of Active Pharmaceutical Ingredients, Injectables, and Proteins

The Future of Wound Care: Why Nanofibers are Key to Accelerated Healing

The Evolution of Lipid Nanoparticles

How Emulsion Electrospinning is Transforming Materials